Onclive.com / Trials



Domain overview in Trials niche. Based on relevant links and pages only.
onclive.com rank
105
Number of domains linking to onclive.com
12
semantic flow
2.52
Number of links to onclive.com
50
semantic flow
2.52
Number of domains linked from onclive.com
1
semantic flow
0.2
Number of links from onclive.com
5
semantic flow
0.2

Popular pages pointing to onclive.com

Pages with highest topical PageRank pointing to domain.

url / atext / target url
https://www.drsusanloveresearch.org/immunotherapy
being studied in patients with triple negative breast cancer
http://www.onclive.com/web-exclusives/checkpoint-inhibitors-show-promise-in-triple-negativ
www.drsusanloveresearch.org
http://www.onclive.com/onclive-tv/dr-rimawi-discusses-patient-selection-in-her2-breast-can
dr brufsky on implementing pertuzumab in her2 breast cancer
http://www.onclive.com/onclive-tv/dr-brufsky-on-implementing-pertuzumab-in-her2-breast-can
http://www.onclive.com/onclive-tv/dr-tripathy-discusses-neratinib-in-her2-breast-cancer
dr rimawi discusses patient selection in her2 breast cancer
http://www.onclive.com/onclive-tv/dr-rimawi-discusses-patient-selection-in-her2-breast-can
http://www.onclive.com/
rituximab lenalidomide regimen misses endpoint in phase iii follicular lymphoma study
http://www.onclive.com/web-exclusives/rituximablenalidomide-regimen-misses-endpoint-in-pha
http://www.onclive.com/conference-coverage/cfs-2017/dr-garon-on-immunotherapy-as-salvage-t
terms conditions
http://www.onclive.com/conference-coverage/cfs-2017/terms
http://www.onclive.com/conference-coverage/cfs-2017/dr-garon-on-immunotherapy-as-salvage-t
dr apolo on toxicity challenges with checkpoint inhibitors in bladder cancer
http://www.onclive.com/onclive-tv/dr-apolo-on-toxicity-challenges-with-checkpoint-inhibito
http://www.onclive.com/onclive-tv/dr-king-discusses-lymph-node-resection-in-breast-cancer
dr davids on ibrutinib plus fcr in younger patients with cll
http://www.onclive.com/onclive-tv/dr-davids-on-ibrutinib-plus-fcr-in-younger-patients-with
http://www.onclive.com/conference-coverage/emuc-2017/dr-mason-on-the-significance-of-the-p
view more from the 2017 emuc congress
http://www.onclive.com/conference-coverage/emuc-2017/conference-coverage/emuc-2017
http://www.onclive.com/conference-coverage/emuc-2017/dr-mason-on-the-significance-of-the-p
terms conditions
http://www.onclive.com/conference-coverage/emuc-2017/terms

Popular pages from onclive.com

On-topic pages from domain with highest topical PageRank.

title / url
PR


info
relevance


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
Dr. Brufsky on Implementing Pertuzumab in HER2+ Breast Cancer
http://www.onclive.com/onclive-tv/dr-brufsky-on-implementing-pertuzumab-in-her2-breast-can
0.280.97102242200
Dr. Rimawi Discusses Patient Selection in HER2+ Breast Cancer
http://www.onclive.com/onclive-tv/dr-rimawi-discusses-patient-selection-in-her2-breast-can
0.281102232200
| Onclive
http://www.onclive.com/insights-archive/metastatic-prostate-cancer/terms
0.280.8291182200
Dr. Kim on the Importance of Biomarker Testing for Lung Cancer
http://www.onclive.com/onclive-tv/dr-kim-on-the-importance-of-biomarker-testing-for-lung-c
0.280.97102212200
Dr. Tripathy Discusses Neratinib in HER2+ Breast Cancer
http://www.onclive.com/onclive-tv/dr-tripathy-discusses-neratinib-in-her2-breast-cancer
0.280.95102242200
Dr. Garon on Immunotherapy as Salvage Treatment for Advanced Lung Cancer
http://www.onclive.com/conference-coverage/cfs-2017/dr-garon-on-immunotherapy-as-salvage-t
0.210.9498212200
Emerging Developments in NETs, Liver Cancer
http://www.onclive.com/web-exclusives/emerging-developments-in-nets-liver-cancer
0.210.7392182200
Dr. King Discusses Lymph Node Resection in Breast Cancer
http://www.onclive.com/onclive-tv/dr-king-discusses-lymph-node-resection-in-breast-cancer
0.210.96104252200
Dr. Warner on the Future of Surgery for Patients With Prostate Cancer
http://www.onclive.com/onclive-tv/dr-warner-on-the-future-of-surgery-for-patients-with-pro
0.210.98103232200
Dr. Mason on the Significance of the PROTECT Study in Prostate Cancer
http://www.onclive.com/conference-coverage/emuc-2017/dr-mason-on-the-significance-of-the-p
0.21196242200

Domains with most semantic flow to onclive.com

Relevant domains with most links to selected domain.

domain info
count


info
semantic flow


info
http://massgeneral.org/ 180.67massgeneral.org
http://lungevity.org/ 130.65lungevity.org
http://breastcancertrials.org/ 80.5breastcancertrials.org
http://scoop.it/ 30.23scoop.it
http://drsusanloveresearch.org/ 10.09drsusanloveresearch.org
http://uvahealth.com/ 10.08uvahealth.com
http://pcctc.org/ 10.08pcctc.org
http://startrktrials.com/ 10.08startrktrials.com
http://army.mil/ 10.04army.mil
http://curetoday.com/ 10.04curetoday.com

Domains with most semantic flow from onclive.com

Relevant domains with most links from selected domain.

domain info
count


info
semantic flow


info
http://gotoper.com/ 50.2gotoper.com

Hubs from onclive.com

Pages from domain with most likely on-topic outgoing links.

url
count


info
PR


info
score


info
semantic flow


info
relevance


info
on topic


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
http://www.onclive.com/publications/oncology-live/2014/august-2014/targeting-the-androgen- 170.150.990.34-1no-1-1-1-111
http://www.onclive.com/specialty/ovarian-cancer 150.160.951.050.98yes124331100
http://www.onclive.com/specialty/prostate-cancer 130.160.950.820.94yes128311100
http://www.onclive.com/specialty/patients 110.160.950.580.87yes123271100
http://www.onclive.com/specialty/genitourinary-cancer 100.160.950.630.98yes128281100
http://www.onclive.com/specialty/colorectal-cancer 70.160.950.370.82yes128241100
http://www.onclive.com/specialty/lung-cancer 60.160.960.230.81yes128231100
http://www.onclive.com/specialty/personalized-medicine 50.160.950.140.59yes128241100
http://www.onclive.com/web-exclusives/tchp-still-standard-choice-for-patients-with-her2-br 10.150.820.040.75yes91182211
http://www.onclive.com/specialty/melanoma 10.160.950.01-1no-1-1-1-100

contact | terms | privacy
© 2018-2024 semanticjuice.com